V-9302 was proved to inhibit HCC growth both in vitro and in vivo, and sensitizes glutamine-dependent HCC cells to glutaminase inhibitor CB-839 treatment [51, 52]. The gene discussed is GLS; the disease is hepatocellular carcinoma.